top of page
Browse by category
Search
FDA approves semaglutide to reduce the risk of worsening kidney disease and cardiovascular death
The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to...
ASN issues guidance on the management of obesity in persons with kidney diseases
The American Society of Nephrology (ASN) has released its inaugural Kidney Health Guidance (KHG) on the Management of Obesity in Persons...
Semaglutide may protect kidney function in individuals with a pre-existing kidney impairment
The latest analysis from the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity Trial (SELECT) has...
Kidney-transplant before and post-bariatric surgery are safe and effective
Kidney-transplant before and post bariatric surgery (BS) are safe and effective approaches to lose weight among end stage renal disease...
Obesity and the increased risk of kidney disease
A study led by University of Manchester and Manchester University NHS Foundation Trust (MFT) researchers has revealed that obesity is...
Browse by tag
bottom of page